T1	CHEM 13 25	metronidazol
#1	AnnotatorNotes T1	C0025872; metronidazole; Organic Chemical · Pharmacologic Substance
T2	PROC 33 40	placebo
#2	AnnotatorNotes T2	C0032042; Placebos; Therapeutic or Preventive Procedure
T3	PROC 47 64	control del dolor
#3	AnnotatorNotes T3	C1304888; Pain control; Therapeutic or Preventive Procedure
T4	PROC 77 93	hemorroidectomía
#4	AnnotatorNotes T4	C0019108; Hemorrhoidectomy; Therapeutic or Preventive Procedure
T5	PROC 638 654	hemorroidectomía
#5	AnnotatorNotes T5	C0019108; Hemorrhoidectomy; Therapeutic or Preventive Procedure
T6	DISO 156 178	enfermedad hemorroidal
T7	PROC 1785 1801	hemorroidectomía
#6	AnnotatorNotes T7	C0019108; Hemorrhoidectomy; Therapeutic or Preventive Procedure
T8	PROC 262 280	cirugía anorrectal
#7	AnnotatorNotes T8	C4763853; Ambulatory Anorectal Surgery; Therapeutic or Preventive Procedure
T9	DISO 305 317	complicación
#8	AnnotatorNotes T9	C0009566; Complication; Pathologic Function
T10	CHEM 329 337	fármacos
#9	AnnotatorNotes T10	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T11	PROC 385 402	control del dolor
#10	AnnotatorNotes T11	C1304888; Pain control; Therapeutic or Preventive Procedure
T12	PROC 429 440	tratamiento
#11	AnnotatorNotes T12	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T13	CHEM 451 463	metronidazol
#12	AnnotatorNotes T13	C0025872; metronidazole; Organic Chemical · Pharmacologic Substance
T14	CHEM 581 593	metronidazol
#13	AnnotatorNotes T14	C0025872; metronidazole; Organic Chemical · Pharmacologic Substance
T15	PROC 601 608	placebo
#14	AnnotatorNotes T15	C0032042; Placebos; Therapeutic or Preventive Procedure
T16	PROC 615 632	control del dolor
#15	AnnotatorNotes T16	C1304888; Pain control; Therapeutic or Preventive Procedure
T17	DISO 728 739	hemorroides
#16	AnnotatorNotes T17	C0019112; Hemorrhoids; Disease or Syndrome
T18	CHEM 795 807	metronidazol
#17	AnnotatorNotes T18	C0025872; metronidazole; Organic Chemical · Pharmacologic Substance
T19	PROC 873 880	placebo
#18	AnnotatorNotes T19	C0032042; Placebos; Therapeutic or Preventive Procedure
T20	PROC 882 912	Se evaluó dolor postquirúrgico
T21	DISO 892 912	dolor postquirúrgico
#19	AnnotatorNotes T21	C0030201; Pain, Postoperative; Sign or Symptom
T22	PROC 917 938	escala visual análoga
#20	AnnotatorNotes T22	C0042815; Visual Analog Pain Scale; Diagnostic Procedure | C2959685; Assessment using visual analog scale; Health Care Activity
T23	PROC 940 943	EVA
#21	AnnotatorNotes T23	C0042815; Visual Analog Pain Scale; Diagnostic Procedure | C2959685; Assessment using visual analog scale; Health Care Activity
T24	PROC 1109 1144	evaluación del dolor postquirúrgico
T25	DISO 1124 1144	dolor postquirúrgico
#22	AnnotatorNotes T25	C0030201; Pain, Postoperative; Sign or Symptom
T26	CHEM 1556 1567	analgésicos
#23	AnnotatorNotes T26	C0002771; Analgesics; Organic Chemical · Pharmacologic Substance · Hazardous or Poisonous Substance
T27	CHEM 1731 1743	metronidazol
#24	AnnotatorNotes T27	C0025872; metronidazole; Organic Chemical · Pharmacologic Substance
T28	PROC 1762 1779	control del dolor
#25	AnnotatorNotes T28	C1304888; Pain control; Therapeutic or Preventive Procedure
T29	DISO 59 64	dolor
#26	AnnotatorNotes T29	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T30	PROC 112 137	ensayo clínico controlado
#27	AnnotatorNotes T30	C0206035; Controlled Clinical Trials, Randomized; Research Activity
T31	ANAT 270 280	anorrectal
#28	AnnotatorNotes T31	C3870603; Anorectal; Body Space or Junction
T32	DISO 286 291	dolor
#29	AnnotatorNotes T32	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T33	DISO 397 402	dolor
#30	AnnotatorNotes T33	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T34	PROC 558 577	administración oral
#31	AnnotatorNotes T34	C0001563; Administration, Oral; Therapeutic or Preventive Procedure | C1273553; Oral administration of treatment; Therapeutic or Preventive Procedure
T35	DISO 627 632	dolor
#32	AnnotatorNotes T35	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T36	PROC 677 702	ensayo clínico controlado
#33	AnnotatorNotes T36	C0206035; Controlled Clinical Trials, Randomized; Research Activity
T37	CHEM 957 968	analgésicos
#34	AnnotatorNotes T37	C0002771; Analgesics; Organic Chemical · Pharmacologic Substance · Hazardous or Poisonous Substance
T38	PROC 1708 1727	administración oral
#35	AnnotatorNotes T38	C0001563; Administration, Oral; Therapeutic or Preventive Procedure | C1273553; Oral administration of treatment; Therapeutic or Preventive Procedure
T39	DISO 1774 1779	dolor
#36	AnnotatorNotes T39	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T40	LIVB 201 208	adultos
#37	AnnotatorNotes T40	C0001675; Adult; Age Group
T41	Age 209 226	mayores a 40 años
T42	Route 339 346	tópicos
#38	AnnotatorNotes T42	C1522168; Topical Route of Drug Administration; Functional Concept
T45	Route 573 577	oral
#39	AnnotatorNotes T45	C1527415; Oral Route of Drug administration; Functional Concept
T46	LIVB 706 723	pacientes adultos
#40	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T48	LIVB 762 778	grupo de estudio
#41	AnnotatorNotes T48	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T49	Dose 808 814	500 mg
T50	Route 815 819	oral
#42	AnnotatorNotes T50	C1527415; Oral Route of Drug administration; Functional Concept
T51	Frequency 820 832	cada 8 horas
T52	Duration 837 843	7 días
T53	LIVB 854 867	grupo control
#43	AnnotatorNotes T53	C0009932; Control Groups; Group
T54	LIVB 869 871	GC
#44	AnnotatorNotes T54	C0009932; Control Groups; Group
T55	Time 898 912	postquirúrgico
#45	AnnotatorNotes T55	C0032790; Postoperative Period; Temporal Concept
T56	LIVB 1029 1038	pacientes
#46	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T58	Time 1130 1144	postquirúrgico
#47	AnnotatorNotes T58	C0032790; Postoperative Period; Temporal Concept
T59	LIVB 1188 1190	GC
#48	AnnotatorNotes T59	C0009932; Control Groups; Group
T60	Duration 1193 1200	las 6 h
T62	Duration 1233 1241	las 12 h
T63	LIVB 1489 1491	GE
#49	AnnotatorNotes T63	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T64	Duration 1271 1279	las 24 h
T65	CONC 1426 1439	primera dosis
T67	Duration 1469 1482	7,09 ± 2,36 h
T68	Duration 1494 1512	21,27 ± 5,47 horas
T69	LIVB 1519 1521	GC
#50	AnnotatorNotes T69	C0009932; Control Groups; Group
T70	Duration 1568 1599	6,86 ± 1,61 y 13,09 ± 2,48 días
T71	Duration 1642 1677	los 7,59 ± 1,56 y 14,73 ± 3,76 días
T72	Route 1723 1727	oral
#51	AnnotatorNotes T72	C1527415; Oral Route of Drug administration; Functional Concept
T43	LIVB 780 782	GE
#52	AnnotatorNotes T43	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T44	LIVB 1183 1185	GE
#53	AnnotatorNotes T44	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T47	LIVB 1419 1421	GE
#54	AnnotatorNotes T47	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T57	Duration 1310 1316;1388 1391	cuarto día
T61	Duration 1347 1354;1388 1391	séptimo día
T66	Duration 1385 1391	14 día
A1	Population_data T40 Age
A2	Population_data T46 Age
T73	CONC 1062 1073	diferencias
A3	Assertion T73 Negated
#55	AnnotatorNotes T73	C1705241; Delta (difference); Quantitative Concept
T74	Neg_cue 1058 1061	sin
R1	Negation Arg1:T74 Arg2:T73	
T75	Neg_cue 416 418	no
R2	Negation Arg1:T75 Arg2:T12	
A4	Assertion T12 Negated
T76	Quantifier_or_Qualifier 441 446	ideal
A5	Assertion T76 Negated
R3	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T76	
R4	Negation Arg1:T75 Arg2:T76	
T77	Neg_cue 503 505	no
T78	Quantifier_or_Qualifier 512 524	generalizado
A6	Assertion T78 Negated
R5	Negation Arg1:T77 Arg2:T78	
R7	After Arg1:T3 Arg2:T4	
R8	Has_Age Arg1:T40 Arg2:T41	
R9	Experiences Arg1:T40 Arg2:T6	
#56	AnnotatorNotes T6	C0019112; Hemorrhoids; Disease or Syndrome
T79	Quantifier_or_Qualifier 740 752	grado III/IV
R10	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T79	
R11	Location_of Arg1:T31 Arg2:T8	
R12	Causes Arg1:T8 Arg2:T32	
R13	Causes Arg1:T8 Arg2:T9	
R14	Experiences Arg1:T40 Arg2:T8	
R15	Experiences Arg1:T40 Arg2:T32	
R16	Experiences Arg1:T40 Arg2:T9	
R17	Has_Route_or_Mode Arg1:T10 Arg2:T42	
T80	Route 349 359	sistémicos
#57	AnnotatorNotes T80	C0205373; Systemic; Functional Concept
R18	Has_Route_or_Mode Arg1:T10 Arg2:T80	
T81	Observation 478 489	disminuirlo
#58	AnnotatorNotes T81	C5230944; Sensation of pain reduced; Finding (?)
R20	Causes Arg1:T13 Arg2:T81	
T82	Observation 548 554	efecto
#59	AnnotatorNotes T82	C1518681; Outcome of Therapy; Finding (?)
R21	Causes Arg1:T34 Arg2:T82	
R22	Used_for Arg1:T14 Arg2:T34	
R23	Has_Route_or_Mode Arg1:T14 Arg2:T45	
R24	Causes Arg1:T15 Arg2:T82	
R26	Causes Arg1:T4 Arg2:T29	
R27	Causes Arg1:T5 Arg2:T35	
R28	After Arg1:T16 Arg2:T5	
R29	Experiences Arg1:T46 Arg2:T17	
R30	Has_Dose_or_Strength Arg1:T18 Arg2:T49	
R31	Has_Route_or_Mode Arg1:T18 Arg2:T50	
R32	Has_Frequency Arg1:T18 Arg2:T51	
R33	Has_Duration_or_Interval Arg1:T18 Arg2:T52	
R34	Experiences Arg1:T54 Arg2:T19	
R35	Experiences Arg1:T53 Arg2:T19	
R36	Experiences Arg1:T48 Arg2:T18	
R37	Experiences Arg1:T43 Arg2:T18	
R38	Overlap Arg1:T21 Arg2:T55	
R42	Overlap Arg1:T21 Arg2:T37	
R43	Overlap Arg1:T37 Arg2:T55	
T83	Observation 971 997	reincorporación al trabajo
#60	AnnotatorNotes T83	C0425105; Return to Work; Finding
R44	After Arg1:T1 Arg2:T4	
R45	After Arg1:T2 Arg2:T4	
R46	After Arg1:T14 Arg2:T5	
R47	After Arg1:T15 Arg2:T5	
R48	Overlap Arg1:T25 Arg2:T58	
R49	Overlap Arg1:T24 Arg2:T25	
R50	Overlap Arg1:T24 Arg2:T60	
R51	Overlap Arg1:T24 Arg2:T62	
R52	Overlap Arg1:T24 Arg2:T64	
R53	Overlap Arg1:T24 Arg2:T57	
R54	Overlap Arg1:T24 Arg2:T61	
R55	Overlap Arg1:T24 Arg2:T66	
R56	Overlap Arg1:T25 Arg2:T60	
R57	Overlap Arg1:T25 Arg2:T62	
R58	Overlap Arg1:T25 Arg2:T64	
R59	Overlap Arg1:T25 Arg2:T61	
R60	Overlap Arg1:T25 Arg2:T66	
R61	Overlap Arg1:T25 Arg2:T57	
R62	Experiences Arg1:T44 Arg2:T24	
R63	Experiences Arg1:T59 Arg2:T24	
R64	Experiences Arg1:T44 Arg2:T25	
R65	Experiences Arg1:T59 Arg2:T25	
R66	Experiences Arg1:T47 Arg2:T25	
R67	Experiences Arg1:T47 Arg2:T24	
R68	Has_Duration_or_Interval Arg1:T26 Arg2:T70	
R69	Has_Dose_or_Strength Arg1:T26 Arg2:T65	
R70	Overlap Arg1:T26 Arg2:T68	
R71	Overlap Arg1:T26 Arg2:T67	
R72	Experiences Arg1:T63 Arg2:T26	
R73	Experiences Arg1:T69 Arg2:T26	
T84	Observation 1613 1639	reincorporación al trabajo
#61	AnnotatorNotes T84	C0425105; Return to Work; Finding
R74	Overlap Arg1:T84 Arg2:T71	
R75	Used_for Arg1:T27 Arg2:T38	
R76	Has_Route_or_Mode Arg1:T27 Arg2:T72	
R77	After Arg1:T28 Arg2:T7	
R78	Causes Arg1:T7 Arg2:T39	
R80	After Arg1:T38 Arg2:T7	
#62	AnnotatorNotes T76	C1512612; Ideal; Qualitative Concept
R6	Has_Dose_or_Strength Arg1:T19 Arg2:T49	
R19	Has_Route_or_Mode Arg1:T19 Arg2:T50	
R25	Has_Frequency Arg1:T19 Arg2:T51	
R83	Has_Duration_or_Interval Arg1:T19 Arg2:T52	
R40	Overlap Arg1:T22 Arg2:T55	
R41	Overlap Arg1:T23 Arg2:T55	
#63	AnnotatorNotes R69	(?)
#64	AnnotatorNotes T65	C5236155; Date of First Dose; Temporal Concept
R39	Overlap Arg1:T20 Arg2:T55	
#65	AnnotatorNotes T78	C0205391; Widespread; Spatial Concept
A7	Experiencer T40 Patient
A8	Experiencer T46 Patient
A9	Experiencer T48 Patient
A10	Experiencer T43 Patient
A11	Experiencer T54 Patient
A12	Experiencer T53 Patient
A13	Experiencer T56 Patient
A14	Experiencer T44 Patient
A15	Experiencer T59 Patient
A16	Experiencer T47 Patient
A17	Experiencer T63 Patient
A18	Experiencer T69 Patient
